Skip to main content

Table 2 Number and percentage of del[5q] detected using metaphase cytogenetics, FISH and SNP-A alone or in combination in myeloid malignancies (N = 122)

From: Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide

 

MC

FISH

SNP

MC+FISH

MC+SNP

FISH+SNP

MC+FISH+SNP

Number

24

27

25

29

30

31

32

Percentage

20%

22%

21%

24%

25%

25%

26%

  1. MC metaphase cytogenetics; FISH fluorescence in situ hybridization; SNP single nucleotide polymorphism array-based karyotyping.